关注
Giovanni Lughezzani
Giovanni Lughezzani
Deparment of Urology, Humanitas Research Hospital
在 humanitas.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature
G Lughezzani, M Burger, V Margulis, SF Matin, G Novara, M Roupret, ...
European urology 62 (1), 100-114, 2012
4412012
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis
M Sun, R Thuret, F Abdollah, G Lughezzani, J Schmitges, Z Tian, ...
European urology 59 (1), 135-141, 2011
3452011
Serum isoform [− 2] proPSA derivatives significantly improve prediction of prostate cancer at initial biopsy in a total PSA range of 2–10 ng/ml: a multicentric European study
M Lazzeri, A Haese, A de la Taille, JP Redorta, T McNicholas, ...
European urology 63 (6), 986-994, 2013
2702013
Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between …
G Guazzoni, L Nava, M Lazzeri, V Scattoni, G Lughezzani, C Maccagnano, ...
European urology 60 (2), 214-222, 2011
2602011
Preoperative pelvic floor muscle exercise for early continence after radical prostatectomy: a randomised controlled study
A Centemero, L Rigatti, D Giraudo, M Lazzeri, G Lughezzani, D Zugna, ...
European urology 57 (6), 1039-1044, 2010
2512010
The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation
G Lughezzani, M Sun, P Perrotte, C Jeldres, A Alasker, H Isbarn, ...
European journal of cancer 46 (4), 713-719, 2010
2402010
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma
G Lughezzani, C Jeldres, H Isbarn, SF Shariat, M Sun, D Pharand, ...
Urology 75 (1), 118-124, 2010
1832010
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients
G Lughezzani, C Jeldres, H Isbarn, M Sun, SF Shariat, A Alasker, ...
European Journal of Cancer 45 (18), 3291-3297, 2009
1742009
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment
M Crépel, C Jeldres, P Perrotte, U Capitanio, H Isbarn, SF Shariat, ...
Urology 75 (2), 271-275, 2010
1632010
Preoperative prostate-specific antigen isoform p2PSA and its derivatives,% p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical …
G Guazzoni, M Lazzeri, L Nava, G Lughezzani, A Larcher, V Scattoni, ...
European urology 61 (3), 455-466, 2012
1562012
Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature
G Lughezzani, A Briganti, PI Karakiewicz, MW Kattan, F Montorsi, ...
European urology 58 (5), 687-700, 2010
1552010
Clinical performance of serum prostate‐specific antigen isoform [‐2] proPSA (p2PSA) and its derivatives,% p2PSA and the prostate health index (PHI), in men with a family …
M Lazzeri, A Haese, A Abrate, A de la Taille, JP Redorta, T McNicholas, ...
BJU international 112 (3), 313-321, 2013
1542013
Margin, ischemia, and complications (MIC) score in partial nephrectomy: a new system for evaluating achievement of optimal outcomes in nephron-sparing surgery.
N Buffi, G Lista, A Larcher, G Lughezzani, V Ficarra, A Cestari, M Lazzeri, ...
European urology 62 (4), 617-618, 2012
1522012
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database
G Lughezzani, M Sun, P Perrotte, SF Shariat, C Jeldres, L Budäus, ...
Urology 75 (2), 321-327, 2010
1522010
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter
C Jeldres, G Lughezzani, M Sun, H Isbarn, SF Shariat, L Budaus, ...
The Journal of urology 183 (4), 1324-1329, 2010
1402010
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma
H Isbarn, C Jeldres, SF Shariat, D Liberman, M Sun, G Lughezzani, ...
The Journal of urology 182 (5), 2177-2181, 2009
1402009
Role of restaging transurethral resection for T1 non–muscle invasive bladder cancer: a systematic review and meta-analysis
A Naselli, R Hurle, S Paparella, NM Buffi, G Lughezzani, G Lista, ...
European urology focus 4 (4), 558-567, 2018
1312018
Treatment of metastatic renal cell carcinoma
M Sun, G Lughezzani, P Perrotte, PI Karakiewicz
Nature Reviews Urology 7 (6), 327-338, 2010
1252010
Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study
G Lughezzani, M Sun, P Perrotte, SF Shariat, C Jeldres, L Budaus, ...
European urology 57 (6), 956-962, 2010
1232010
A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma
C Jeldres, M Sun, H Isbarn, G Lughezzani, L Budäus, A Alasker, ...
Urology 75 (2), 315-320, 2010
1202010
系统目前无法执行此操作,请稍后再试。
文章 1–20